<DOC>
	<DOCNO>NCT02000661</DOCNO>
	<brief_summary>Fractional flow reserve ( FFR ) test perform time heart catheterization . It measure change pressure across narrow heart artery high flow situation , provide reliable information functional severity narrow . FFR measurement accurately predict whether stent need , consider excellent test placement stent treat narrow heart artery . However , FFR use every case extra time need associated device cost . Cardiac Services BC ( agency Provincial Health Services Authority ) sponsor study find FFR use case ( routine ) , rather current selective approach .</brief_summary>
	<brief_title>Routine Versus Selective Use FFR Guide PCI</brief_title>
	<detailed_description>Percutaneous coronary intervention ( PCI ) effective , less invasive mode revascularization compare coronary artery bypass grafting ( CABG ) . In 2011 , total 7,614 PCI procedure perform British Columbia ( BC ) . While procedure do emergently life-threatening indication ( e.g . ST elevation myocardial infarction - STEMI cardiogenic shock ) , ( 6,169 case year 2011 ) do discretion treat physician , take patient preference account . A number factor usually consider proceeding PCI . These may include clinical presentation ( stable angina versus acute coronary syndrome ) ; severity symptom ( asymptomatic highly symptomatic ) ; response medical therapy ; severity ischemia base non-invasive functional testing ( mild , moderate , severe ) ; predict risk ( low , intermediate , high ) ; finding coronary angiography ( lesion number , location , severity , morphology , etc ) . However , interpretation symptom subjective . Non-invasive test ischemia may reliable . In addition , coronary angiography use 2 dimensional image depict 3-dimensional structure , well know limitation . The concept use fractional flow reserve ( FFR ) predict functional significance coronary lesion describe &gt; 20 year ago . In 1996 , Pijls et al show measurement FFR cardiac catheterization laboratory accurately predict provoke ischemia upon non-invasive functional testing . The DEFER study ( 2007 ) show coronary lesion non-ischemic FFR value treat medical therapy good clinical outcome 5-year follow . The FAME-1 study ( 2009 ) evaluate strategy PCI guide angiography versus PCI guide FFR measurement multi-vessel disease . The primary end-point 1-year composite death , myocardial infarction ( MI ) , repeat revascularization . Fewer stent use per patient FFR-guided group ( 2.7 versus 1.9 stent per patient ) , less contrast agent use ( 302 versus 272 ml ) , low in-lab equipment cost ( $ 6,007 US versus $ 5,332 US ) , significant P &lt; 0.001 . A total 1,005 patient randomize . At 1-year follow , composite end-point death , MI target vessel revascularization 18.2 % angiography-guided group versus 13.3 % FFR-guided group ( p &lt; 0.02 ) . At 2-year follow , incidence death MI low FFR-guided group ( 12.7 % versus 8.4 % , p &lt; 0.03 ) , incidence MI FFR-guided PCI defer population low 0.2 % . Since publication FAME-1 study , use pressure wire measure FFR increase ~400 case per year ~1,000 case per year BC . However , comparison annual non-emergent PCI volume &gt; 6,000 case per year , use FFR appear highly selective ( 1,058 6,169 , 17 % , base year 2011 statistic ) . In series 442 consecutive FFR case do Vancouver General St. Paul 's Hospitals ( year 2011 2012 ) , use FFR identify non-ischemic lesion 52 % , result change management decision 68 % . In addition , provincial data show significant variation use FFR among 5 PCI capable hospital BC ( &lt; 5 % ~30 % ) . Based recent European Society Cardiology guideline , use FFR guide revascularization class 1a indication multi-vessel disease , US guideline ( American College Cardiology , ACC ) class 2a recommendation use FFR evaluate coronary lesion intermediate severity . It possible highly selective approach use FFR may lead underuse , turn may lead overuse PCI , increase cost , adverse clinical outcome . We hypothesize routine use FFR may improve clinical outcome , decrease number PCI , decrease direct cost cardiac catheterization laboratory . We propose randomize study compare 2 approach use FFR guide PCI : ( 1 ) routine use - experimental arm ; ( 2 ) selective use - current standard .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<criteria>1 . Subjects stable coronary artery disease recent acute coronary syndrome ( ACS ) . Subjects present ST elevation myocardial infarction ( STEMI ) allow included 5 day initial presentation . 2 . At least one obstructive coronary lesion present vessel reference diameter ≥2.5 mm diameter stenosis ≥50 % visual estimate . Lesions must technically suitable FFR procedure angioplasty stent placement . 3 . Physician classify target lesion need FFR randomization , plan perform nonemergent PCI . 4 . Subject ≥18 year old , sign informed consent . 1 . Expected noncardiac longevity &lt; 2 year . 2 . Planned treatment CABG . 3 . Planned treatment medical therapy . 4 . Left main disease &gt; 50 % diameter stenosis base visual estimate . 5 . Safety issue : 1 . Unstable hemodynamics serious arrhythmias procedure ; 2 . Ongoing ischemic chest pain ; 3 . High grade AV block ( unless pacemaker ) ; 4 . Allergic adenosine . 6 . When FFR clearly need : 1 . Target vessel slow flow ( &lt; TIMI3 ) ; 2 . Single vessel disease ≥90 % stenosis ; 3 . Single vessel disease ≥80 % stenosis document ischemia functional imaging test ; 4 . In acute coronary syndrome , ≥70 stenosis identify culprit . 7 . When FFR clearly need target lesion : declare operator . 8 . Technical difficulty : 1 . Severe vessel tortuosity ; 2 . Severe coronary calcification ; 3 . Anticipate difficult wiring ; 4 . Aortoostial lesion ( ok IV adenosine use hyperemic agent ) . 9 . Interpretation difficulty : 1 . Target vessel act major collateral donor ; 2 . When RA pressure high ; 3 . STEMI within past 5 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Fractional Flow Reserve ( FFR )</keyword>
	<keyword>FFR guide coronary intervention</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>